485 related articles for article (PubMed ID: 17593366)
21. Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.
Dietrich CS; Greenberg VL; DeSimone CP; Modesitt SC; van Nagell JR; Craven R; Zimmer SG
Gynecol Oncol; 2010 Jan; 116(1):126-30. PubMed ID: 19875160
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF
BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771
[TBL] [Abstract][Full Text] [Related]
23. Molecular sequelae of histone deacetylase inhibition in human retinoblastoma cell lines: clinical implications.
Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMullan C; Miller JW; Marks PA; Mitsiades N
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4072-9. PubMed ID: 19387079
[TBL] [Abstract][Full Text] [Related]
24. Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines.
Yamamoto S; Tanaka K; Sakimura R; Okada T; Nakamura T; Li Y; Takasaki M; Nakabeppu Y; Iwamoto Y
Anticancer Res; 2008; 28(3A):1585-91. PubMed ID: 18630516
[TBL] [Abstract][Full Text] [Related]
25. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest.
Li GC; Zhang X; Pan TJ; Chen Z; Ye ZQ
Int J Urol; 2006 May; 13(5):581-6. PubMed ID: 16771729
[TBL] [Abstract][Full Text] [Related]
26. Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivo.
Park KC; Kim SW; Park JH; Song EH; Yang JW; Chung HJ; Jung HJ; Suh JS; Kwon HJ; Choi SH
Cancer Sci; 2011 Feb; 102(2):343-50. PubMed ID: 21159061
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of cervical cancer cells treated with suberonylanilide hydroxamic acid.
He J; Huang C; Tong A; Chen B; Zeng Z; Zhang P; Wang C; Wei Y
J Biosci; 2008 Dec; 33(5):715-21. PubMed ID: 19179759
[TBL] [Abstract][Full Text] [Related]
28. Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer.
Liu L; Zhao L; Zhang Y; Zhang Q; Ding Y
Cell Biol Int; 2007 Aug; 31(8):805-14. PubMed ID: 17376711
[TBL] [Abstract][Full Text] [Related]
29. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
[TBL] [Abstract][Full Text] [Related]
30. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
Rikiishi H; Shinohara F; Sato T; Sato Y; Suzuki M; Echigo S
Int J Oncol; 2007 May; 30(5):1181-8. PubMed ID: 17390020
[TBL] [Abstract][Full Text] [Related]
31. Anti-cancer effect of Betulin on a human lung cancer cell line: a pharmacoproteomic approach using 2 D SDS PAGE coupled with nano-HPLC tandem Mass Spectrometry.
Pyo JS; Roh SH; Kim DK; Lee JG; Lee YY; Hong SS; Kwon SW; Park JH
Planta Med; 2009 Feb; 75(2):127-31. PubMed ID: 19085751
[TBL] [Abstract][Full Text] [Related]
32. Proteomics analysis of kojic acid treated A375 human malignant melanoma cells.
Nawarak J; Huang-Liu R; Kao SH; Liao HH; Sinchaikul S; Chen ST; Cheng SL
J Proteome Res; 2008 Sep; 7(9):3737-46. PubMed ID: 18630942
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines.
Shen J; Huang C; Jiang L; Gao F; Wang Z; Zhang Y; Bai J; Zhou H; Chen Q
Biochem Pharmacol; 2007 Jun; 73(12):1901-9. PubMed ID: 17445779
[TBL] [Abstract][Full Text] [Related]
34. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A].
Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126
[TBL] [Abstract][Full Text] [Related]
35. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
[TBL] [Abstract][Full Text] [Related]
36. Up-regulated manganese superoxide dismutase expression increases apoptosis resistance in human esophageal squamous cell carcinomas.
Hu H; Luo ML; Du XL; Feng YB; Zhang Y; Shen XM; Xu X; Cai Y; Han YL; Wang MR
Chin Med J (Engl); 2007 Dec; 120(23):2092-8. PubMed ID: 18167182
[TBL] [Abstract][Full Text] [Related]
37. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents.
Dong G; Wang L; Wang CY; Yang T; Kumar MV; Dong Z
J Pharmacol Exp Ther; 2008 Jun; 325(3):978-84. PubMed ID: 18310471
[TBL] [Abstract][Full Text] [Related]
38. Differential protein profiling in renal-cell carcinoma.
Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA
Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329
[TBL] [Abstract][Full Text] [Related]
39. [Screening of differentially expressed proteins from human esophageal cancer and esophageal tissues by two-dimensional difference gel electrophoresis and mass spectrometry].
Huang ZY; Xiong G; Zhang J; Wang WJ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1406-9. PubMed ID: 17884789
[TBL] [Abstract][Full Text] [Related]
40. Identification of proteins secreted from leptin stimulated MCF-7 breast cancer cells: a dual proteomic approach.
Perera CN; Spalding HS; Mohammed SI; Camarillo IG
Exp Biol Med (Maywood); 2008 Jun; 233(6):708-20. PubMed ID: 18408141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
